Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin (ASTROH)

Conditions

Diseases of the Cardiovascular System

Phase II

Volunteers
Health Professionals

What is the purpose of this trial?

A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden.

Ages
18 years - 70 years
Gender
Both

Find out more about who can participate in this trial

Trial with
University of Louisville
Start Date
05/31/2017
End Date
01/31/2018

For more information about this study, contact:

Lindsey Fraczkiewicz

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Charles Matouk, MD
Associate Professor of Neurosurgery; Vice Chair of Clinical Affairs, Neurosurgery; Chief, Neurovascular Surgery; Director, Neurovascular/Endovascular Fellowship

Sub-Investigators

Last Updated
02/22/2018
Study HIC
#1601017127

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin (ASTROH)

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information